By: | Posted on: | Category:

Parkinson's Disease (PD) is a relentless neurodegenerative disorder. While the tremors and rigidity are visible, the cognitive decline is often the most debilitating non-motor symptom. It attacks memory and executive function. New research confirms that a simple, available tool can slow this decline. It is not a new drug. It's movement.

Why it matters

Physical activity is a neuroprotective intervention. It structurally slows cognitive decline in the disease’s early stages. This moves activity from "nice-to-have" to "structural medicine." Clinicians should use physical activity as a primary defense against the temporoparietal thinning that characterizes PD cognitive decline.

By the numbers

  • 120 patients with early PD were tracked.
  • Over 4 years of serial MRI scans and activity assessments.
  • 33% of participants were women.

1 big idea

Exercise is medicine for the PD brain. The benefit is structural.

  • Regular movement shields the brain’s gray matter from neurodegeneration.
  • This mechanism contributes directly to preserved cognitive function.
  • Physical activity is a key intervention to delay disease progression.

 

 

The Anatomy of Protection

Researchers used the Parkinson's Progression Markers Initiative (PPMI) to quantify how movement shields the brain.

  • Slower cortical thinning occurred in the lateral temporal cortex, fusiform gyrus, and inferior parietal cortex.
  • Slower volume loss was measured in the hippocampus and the amygdala.
  • These structural changes mediate the association with a slower decline in memory and attention. The physical change drives the cognitive benefit.

Reality check

Context is critical for clinical application:

  • The study was observational. It shows association, not direct cause-and-effect.
  • Activity levels relied on the Physical Activity Scale for the Elderly (PASE) self-reports.
  • Clinical application is currently validated only for early-stage PD patients.

The bottom line

Stop viewing exercise as optional. It is a non-pharmacological tool that directly impacts the biological progression of cognitive decline. Prescribe movement today.

 

Sertoma Speech & Hearing Centers
is a 501(c)(3). EIN: 36-2882864.

© 2024, Sertoma Speech & Hearing Centers

Contact Us

Crest Hill
P 630-633-5060
F 630-633-5064

Palos Hills
P 708-599-9500
F 708-599-2791